Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Impact of RT-CGM Reimbursement in Belgium: a Multicenter Real-life Observational Study

NCT02601729 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT02601729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02601729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Impact of RT-CGM Reimbursement in Belgium: a Multicenter Real-life Observational Study
Lead sponsor
KU Leuven
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
January 18, 2019
Enrollment
589 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, type 1